Patent ID: 9694023
Date: 2017-07-04
CPC Classifications: A61K,C07D,C07F

Claim:
1. A method of safely and effectively delivering zoledronic acid to the blood of a human being through repeated oral administration comprising: mixing zoledronic acid with a diluent, binder, an excipient, a disintegrating agent, a flavoring agent, or a lubricant to form a pharmaceutical composition containing at least 20% zoledronic acid by weight; wherein the pharmaceutical composition is in the form of a pill, tablet, or capsule, and containing about 0.15 millimoles to about 1.1 millimoles of zoledronic acid in the acid or a salt form; and wherein the pill, tablet, or capsule is orally administered to a human being at least twice a month and no more frequently than once a day.